OUR HISTORY

Protecting Life


We Work to Deliver Vaccines that can Protect Millions Around MENA Region.







2005

Established

Arabio was established as a leading vaccine manufacture in GCC region.

2006

Strategic Partners

New Strategic Partners have joined Arabio to support company efforts and access other Arabian markets.

2009

Facility Civil

Arabio Facility Civil Work Completion.

2010

Entered the Vaccine Market

Arabio has signed a First License agreement with Novartis vaccines to manufacture & promote its vaccines in MENA region.

2011

First Launch in Saudi Private Market

Aramen Meningococcal conjugate ACWY vaccine.

2012

Expanded in Vaccine Business

Arabio has signed a License agreement with InterVax to manufacture & promote its vaccines in MENA region.

2013

Entered Biological Market

Arabio has signed Toll manufacture agreement with Abbvie to locally manufacture its biological products.

2014

Continued Expansion in Vaccine Market

Arabio has signed Toll manufacture agreement with GSK Vaccines to manufacture all GSK liquid vaccine.

2015

Strengthened our Position in Vaccine & Biological Markets:

Arabio has signed a License agreement with BioFarma to manufacture & promote its WHO prequalified vaccines in MENA region.

Arabio has signed Toll manufacture agreement with Janssen to locally manufacture its biological products.

kEEP IN TOUCH